Strategic partnerships Dendi actively expands through partnerships with Get Well Urgent Care, Molecularlabpartners, Adela, and Atlantic Diagnostic Laboratories, signaling ongoing channel-driven growth opportunities for labs, clinics, and multisite networks that could benefit from Dendi's LIS integrations and scalable workflows.

Expansion into multi-location labs Recent client acquisition of Atlantic Diagnostic Laboratories and collaborations aimed at launching multi-location lab networks indicate a market demand for scalable cloud-based LIS solutions across fragmented regional labs and urgent care networks.

Diversified modality support Dendi supports a wide range of testing modalities from routine clinical chemistry to molecular and genomics, presenting opportunities to upsell modules or integrations to labs expanding into niche or high-complexity testing areas such as oncology, genomics, and esoteric assays.

Strong integration focus With an in-house integrations team handling interfaces to instruments, EHR/EMR, billing, and third-party services, target prospects with complex IT ecosystems or legacy systems seeking modernization and seamless data interoperability.

Financial and growth signals A mid-market footprint with revenue in the tens of millions and recent funding rounds, plus multiple customer wins, suggests readiness for additional investments in scalability, security, and analytics capabilities that can be positioned to enterprise lab networks seeking robust LIS platforms.